Brief: Sensorion Launches Capital Increase Of Maximum 4.466.245 New Ordinary Shares

Sensorion SA

17/05/2018 18:05

May 17 (Reuters) - SENSORION SA  ALSEN.PA :
    * LAUNCHES A SHARE CAPITAL INCREASE OF NEWLY ISSUED ORDINARY
SHARES
    * FUNDS RAISED AIM AT FINANCING PHASE 2 CLINICAL TRIAL FOR
SENS-111,  INITIATION OF PHASE 2 CLINICAL TRIAL FOR SENS-401 AND
PREPARATION OF PHASE 2 TRIAL FOR PREVENTION OF OTOTOXICITY
INDUCED BY CISPLATIN IN PEDIATRIC POPULATION
    * CAPITAL RAISE WOULD CORRESPOND TO A MAXIMUM OF 4.466.245
ORDINARY SHARES
    * SETTLEMENT AND DELIVERY OF THE NEW SHARES AND THE NEW
SHARES’
ADMISSION TO TRADING ARE EXPECTED TO OCCUR ON MAY 22, 2018
    * INNOBIO (BPIFRANCE INVESTISSEMENT) HAS INDICATED AN
INTENTION TO
SUBSCRIBE UP TO 30 % OF THE MAXIMUM NUMBER OF NEW SHARES

Source text : https://bit.ly/2IurrNw
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))